Egret Therapeutics
PrivateLast Round
Seed
Feb 15, 2022
Company Overview
Egret Therapeutics is a biotechnology company that develops pharmaceutical drugs designed to treat neurological diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Egret Therapeutics Comparables
Compare Egret Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aeromics | 81% | |
| Remedy Pharmaceuticals | 80% | |
| ZZ Biotech | 74% | |
Egret Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 15, 2022 |
Egret Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Turret Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 24, 2024
Grew 300% QoQ from 1 to 4 employees.
Egret Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Egret Therapeutics's valuation, stock price, and market status.